399 related articles for article (PubMed ID: 29216925)
21. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
22. Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis.
Cao H; Wang D; Sun P; Chen L; Feng Y; Gao R
Aging (Albany NY); 2021 Oct; 13(19):23096-23107. PubMed ID: 34613933
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
[TBL] [Abstract][Full Text] [Related]
24. ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro.
Tan G; Jiang L; Li G; Bai K
Technol Cancer Res Treat; 2020; 19():1533033820948062. PubMed ID: 33063634
[TBL] [Abstract][Full Text] [Related]
25. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Zhang W; Xin J; Lai J; Zhang W
Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
26. Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells.
Gupta S; Weston A; Bearrs J; Thode T; Neiss A; Soldi R; Sharma S
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):349-357. PubMed ID: 27349498
[TBL] [Abstract][Full Text] [Related]
27. Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells.
Wang Q; He WY; Zeng YZ; Hossain A; Gou X
Int Urol Nephrol; 2018 Apr; 50(4):675-686. PubMed ID: 29460131
[TBL] [Abstract][Full Text] [Related]
28. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer.
Shao N; Ma G; Zhang J; Zhu W
BMC Urol; 2018 Mar; 18(1):14. PubMed ID: 29506516
[TBL] [Abstract][Full Text] [Related]
29. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
[TBL] [Abstract][Full Text] [Related]
30. MiR-193a-5p suppresses cell proliferation and induces cell apoptosis by regulating HOXA7 in human ovarian cancer.
Wang S; Diao YJ; Zhu BB
Neoplasma; 2020 Jul; 67(4):825-833. PubMed ID: 32305054
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27.
Jiang J; Xie C; Liu Y; Shi Q; Chen Y
Biomed Pharmacother; 2019 Jan; 109():595-601. PubMed ID: 30399596
[TBL] [Abstract][Full Text] [Related]
32. A double-negative feedback loop between E2F3b and miR- 200b regulates docetaxel chemosensitivity of human lung adenocarcinoma cells.
Gao Y; Chen L; Song H; Chen Y; Wang R; Feng B
Oncotarget; 2016 May; 7(19):27613-26. PubMed ID: 27027446
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.
Lin HM; Nikolic I; Yang J; Castillo L; Deng N; Chan CL; Yeung NK; Dodson E; Elsworth B; Spielman C; Lee BY; Boyer Z; Simpson KJ; Daly RJ; Horvath LG; Swarbrick A
Sci Rep; 2018 May; 8(1):7820. PubMed ID: 29777112
[TBL] [Abstract][Full Text] [Related]
34. miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics.
Sossey-Alaoui K; Plow EF
Mol Cancer Res; 2016 Feb; 14(2):228-38. PubMed ID: 26474967
[TBL] [Abstract][Full Text] [Related]
35. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
36. MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.
Lin CH; Tsai CH; Yeh CT; Liang JL; Hung WC; Lin FC; Chang WL; Li HY; Yao YC; Hsu TI; Lee YC; Wang YC; Sheu BS; Lai WW; Calkins MJ; Hsiao M; Lu PJ
Oncotarget; 2016 Jun; 7(26):39680-39693. PubMed ID: 27203740
[TBL] [Abstract][Full Text] [Related]
37. The lncRNA OGFRP1/miR-149-5p/IL-6 axis regulates prostate cancer chemoresistance.
Wang C; Ding T; Yang D; Zhang P; Hu X; Qin W; Zheng J
Pathol Res Pract; 2021 Aug; 224():153535. PubMed ID: 34293716
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
[TBL] [Abstract][Full Text] [Related]
39. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1.
Ma H; Yuan L; Li W; Xu K; Yang L
J Cell Biochem; 2018 Nov; 119(10):8325-8335. PubMed ID: 29968942
[TBL] [Abstract][Full Text] [Related]
40. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells.
Fujita Y; Kojima T; Kawakami K; Mizutani K; Kato T; Deguchi T; Ito M
Prostate; 2015 Oct; 75(14):1568-78. PubMed ID: 26074357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]